These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4391629)

  • 1. Osseal changes in young mice undergoing graft-versus-host reaction.
    Berek L; Bános Z; Anderlik P; Szeri I; Aszódi K
    Experientia; 1970 Jan; 26(1):92-3. PubMed ID: 4391629
    [No Abstract]   [Full Text] [Related]  

  • 2. Osseal changes in mice following neonatal thymectomy.
    Berek L; Bános Z; Szeri I; Anderlik P; Aszódi K
    Experientia; 1968 Jul; 24(7):721-3. PubMed ID: 5705248
    [No Abstract]   [Full Text] [Related]  

  • 3. A method for osseal radiomicrometric measurements in mice experiments.
    Berek L
    Experientia; 1969 Jun; 25(6):633-4. PubMed ID: 5800131
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of Escherichia coli endotoxin on the graft-versus-host reaction in mice. 3. Runt disease in newborns.
    Skopińska E
    Arch Immunol Ther Exp (Warsz); 1974; 22(3):305-8. PubMed ID: 4151942
    [No Abstract]   [Full Text] [Related]  

  • 5. Skeletal changes in murine runt disease.
    Simmons DJ; Simmons RL
    Am J Anat; 1967 Jul; 121(1):15-28. PubMed ID: 4167698
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of graft-versus-host reaction and lymphocytic choriomeningitis infection in mice: histopathological changes.
    Koltay M; Radnai B; Bános Z; Szeri I; Anderlik P; Virág I
    Experientia; 1969 Oct; 25(10):1081-3. PubMed ID: 4391047
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and pathologic characteristics of graft-versus-host disease produced in cyclophosphamide-treated adult mice.
    Sandberg JS; Owens AH; Santos GW
    J Natl Cancer Inst; 1971 Jan; 46(1):151-60. PubMed ID: 4395991
    [No Abstract]   [Full Text] [Related]  

  • 8. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects.
    Ueha S; Murai M; Yoneyama H; Kitabatake M; Imai T; Shimaoka T; Yonehara S; Ishikawa S; Matsushima K
    J Leukoc Biol; 2007 Jan; 81(1):176-85. PubMed ID: 17053165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone changes in young mice with impaired lymphoid system.
    Berek L; Bános S; Szeri I; Anderlik P; Aszódi K
    Acta Microbiol Acad Sci Hung; 1975; 22(1):1-8. PubMed ID: 1089352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-thymectomy autoimmune phenomena in mice. II. Morphologic observations.
    Yunis EJ; Teague PO; Stutman O; Good RA
    Lab Invest; 1969 Jan; 20(1):46-61. PubMed ID: 4393547
    [No Abstract]   [Full Text] [Related]  

  • 11. Graft-versus-host reaction in F 1 recipients in the absence of donor (parental) cell proliferation.
    Scollay RG; Hofman F; Globerson A
    Eur J Immunol; 1974 Jul; 4(7):490-3. PubMed ID: 4153366
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in the skin due to the graft-versus-host reaction. 1. Pathogenesis and diagnosis].
    Dobrić I; Vujasinović S; Kastelan A; Baricević B; Labar B; Bogdanić V; Nemet D
    Lijec Vjesn; 1988 Dec; 110(12):436-8. PubMed ID: 3246943
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of naturally occurring suppressor cells of systemic graft versus host reaction (GvHR in fetal and newborn mice.
    Rybczyńska Z; Sajak A; Skowron-Cendrzak A
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):341-5. PubMed ID: 6457582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous manifestations of graft versus host reaction].
    Aractingi S; Carosella ED; Gluckman E
    Ann Dermatol Venereol; 1998 Sep; 125(9):620-7. PubMed ID: 9805557
    [No Abstract]   [Full Text] [Related]  

  • 15. Exeriments for the production of graft-versus-host reaction in newborn mice by means of human immunocompetent cells.
    Osz E; Réthy L
    Ann Immunol Hung; 1975; 18():171-9. PubMed ID: 17348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of graft-versus-host reaction and lymphocytic chroiomeningitis infection in mice.
    Koltay M; Virág I; Bános Z; Anderlik P; Szeri I
    Experientia; 1968 Jan; 24(1):63-5. PubMed ID: 5637623
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal graft-versus-host disease following transfusion of granulocytes from normal donors.
    Ford JM; Cullen MH; Lucey JJ; Tobias JS; Lister TA
    Lancet; 1976 Nov; 2(7996):1167-9. PubMed ID: 62996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
    Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
    J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histopathology of graft-versus-host disease.
    Farmer ER
    Adv Dermatol; 1986; 1():173-88. PubMed ID: 3079242
    [No Abstract]   [Full Text] [Related]  

  • 20. Graft-versus-host disease. Morphologic variation and differential diagnosis in 8 cases of HL-A matched bone marrow transplantation.
    Krüger GR; Berard CW; DeLellis RA; Graw RG; Yankee RA; Leventhal BG; Rogentine GN; Herzig GP; Halterman RH; Henderson ES
    Am J Pathol; 1971 May; 63(2):179-202. PubMed ID: 4397431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.